Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and …

FM Johnson, B Saigal, M Talpaz, NJ Donato - Clinical cancer research, 2005 - AACR
Purpose: Epithelial tumors, including non–small cell lung cancer (NSCLC) and head and
neck squamous cell carcinoma (HNSCC), present clinical challenges. One potential target …
被引用次数：398 相关文章

Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and …

FM Johnson, B Saigal, M Talpaz… - Clinical Cancer Research …, 2005 - europepmc.org
Purpose Epithelial tumors, including non-small cell lung cancer (NSCLC) and head and
neck squamous cell carcinoma (HNSCC), present clinical challenges. One potential target …

[引用][C] Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma …

FM JOHNSON, B SAIGAL, M TALPAZ… - Clinical cancer …, 2005 - pascal-francis.inist.fr
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell
cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell …

Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and …

FM Johnson, B Saigal, M Talpaz… - Clinical Cancer …, 2005 - mdanderson.elsevierpure.com
Purpose: Epithelial tumors, including non-small cell lung cancer (NSCLC) and head and
neck squamous cell carcinoma (HNSCC), present clinical challenges. One potential target …

Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma …

FM Johnson, B Saigal, M Talpaz, NJ Donato - Clinical Cancer Research, 2005 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: Epithelial tumors, including non–
small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC) …

Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and …

FM Johnson, B Saigal, M Talpaz… - … cancer research: an …, 2005 - pubmed.ncbi.nlm.nih.gov
Purpose Epithelial tumors, including non-small cell lung cancer (NSCLC) and head and
neck squamous cell carcinoma (HNSCC), present clinical challenges. One potential target …

[引用][C] Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma …

FM JOHNSON, B SAIGAL… - Clinical …, 2005 - American Association for Cancer …